Happen Bank's LevelUp Savings account currently offers a high 4.20% APY, significantly above the national average of 0.37%. To earn this rate, account holders must deposit at least $250 monthly, which acts as a forced savings mechanism. The account has no fees, no minimum balance, and includes an ATM card with free nationwide access and fee reimbursements. It is FDIC insured, making it a strong option for emergency funds or savings needing easy access and competitive interest.
Happen Bank's LevelUp Savings account offers a notably high 4.20% APY, well above the national average of 0.37%. For readers following Financials-sector US stocks on Pluang, here is the market snapshot as of Sep 25, 2026 18:13 WIB: out of 85 priced stocks, 63 rose and 15 fell. Notable movers include MARA at USD 13.16 (+1.86%, 90% Sell / 10% Buy), HOOD at USD 122.86 (+1.69%, 10% Sell / 90% Buy), and BTBT at USD 1.82 (+1.68%, 57% Sell / 43% Buy).
Assured Guaranty Ltd. (NYSE: AGO) saw its stock price pressured to a new 52-week low of $68.04 despite a recent upgrade to "Buy" by Roth Capital. The company is involved in the financial restructuring of Brightline Florida, where a subsidiary insured...
Legacy Education Inc. reported Q4 2026 earnings with an EPS of $0.13, missing analyst estimates of $0.15, and revenue of $20.1 million, slightly below expectations. Despite this, the company achieved a 12% year-over-year revenue increase in Q4 and a ...
Carnival Corporation & plc is set to report Q3 earnings with analysts forecasting $8.39 billion in revenue and $1.36 EPS, reflecting a 4.9% decline from last year. The company's stock has dropped 27% recently due to a 30% surge in Brent oil prices, w...
Oklo, a pre-revenue nuclear tech company, is developing advanced small modular reactors (SMRs) called Aurora Powerhouses aimed at clean energy for data centers. UBS set a price target of $41, indicating a 7.08% upside from the current $38.29 stock pr...
AbbVie and Johnson & Johnson are both strong dividend stocks trading near their 52-week highs, but they differ significantly in risk and growth. AbbVie shows faster revenue growth and a higher dividend yield, driven by its immunology drugs, but faces...
